# Phase 4bm-X — Merge Closeout

**Merge-closeout standard:** `docs/00-meta/process/merge-closeout-standard.md` (full 16-section structure).
**Risk tier:** Tier 1 — Full Phase per `docs/00-meta/process/phase-risk-tiering-standard.md` §3.

**Phase 4bm-X is now merge-complete on main.**

**Phase 4bm-X is a docs-only descriptive diagnostics interpretation memo.** **Phase 4bm-X does not run diagnostics.** **Phase 4bm-X does not run ML.** **Phase 4bm-X does not define or run strategy.** **Phase 4bm-X does not run backtests.** **Phase 4bm-X does not authorize acquisition.** **Phase 4bm-X does not authorize research execution.** **Phase 4bm-X does not create ML artefacts.** **Phase 4bm-X does not create diagnostic artefacts.** **Phase 4bm-X does not perform feature selection.** **Phase 4bm-X does not perform model selection.** **Phase 4bm-X does not perform threshold tuning.** **Phase 4bm-X does not use the test holdout for tuning or design.** **Phase 4bm-X does not mutate any manifest.** **Phase 4bm-X does not mutate any successor-state artefact.** **Phase 4bm-X does not commit data/microstructure.** **Phase 4bm-X does not commit data/research.** **Any ML-readiness scoping requires a separately authorized memo phase.** **Phase 4bm-Y is not authorized by Phase 4bm-X.** **Recommended state remains paused.**

---

## 1. Phase identity

- **Phase:** Phase 4bm-X — Multi-Day V002 Descriptive Diagnostics Interpretation Memo.
- **Type:** docs-only governance / interpretation memo (interprets the Phase 4bm-W descriptive diagnostics result and evaluates whether a future ML-readiness scoping memo may be proposed).
- **Action:** merge into `main`.
- **Merge purpose:** bring the Phase 4bm-X interpretation memo, its paired closeout, and the narrow `current-project-state.md` Phase 4bm-X block onto `main`, making the phase project-complete. The phase answered a single governance question — given the Phase 4bm-W verdict `DESCRIPTIVE_DIAGNOSTICS_PASS_WITH_CAVEATS`, do the diagnostics support proposing a future ML-readiness scoping memo, and under what constraints — and recorded the decision `RECOMMEND_AUTHORIZE_ML_READINESS_SCOPING_MEMO`. **Phase 4bm-X is a docs-only descriptive diagnostics interpretation memo.**
- **Target branch:** `main`.
- **Source branch:** `phase-4bm-x/multi-day-v002-descriptive-diagnostics-interpretation-memo`.

## 2. Source branch

`phase-4bm-x/multi-day-v002-descriptive-diagnostics-interpretation-memo`

## 3. Base SHA

`e4067c08c88e6dd8354a15bc90e90aa55ddada39` (Phase 4bm-W merge-closeout SHA-finalization commit `docs(phase-4bm-w): finalize merge closeout shas`; `main == origin/main` before merge). The Phase 4bm-W merge commit `cd8913a273c030dd5a2e6e5e5eeab142fd1ffda4` and merge-closeout commit `da76f8e07f2cfe6f74816cbc3892ee100bc7b94f` are present on `main` immediately below this base.

## 4. Branch tip SHA before merge

`199c8c8a840a9614d61f03c93d18df5364559bb4` (commit `docs(phase-4bm-x): interpret descriptive diagnostics result`). This is also the docs commit (the phase produced exactly one commit on the branch).

## 5. Docs commit SHA

`199c8c8a840a9614d61f03c93d18df5364559bb4` (`docs(phase-4bm-x): interpret descriptive diagnostics result`) — adds the interpretation memo, the closeout, and the narrow `current-project-state.md` block.

## 6. Merge commit SHA

`70e13ebd9133684e6e8c1d24c2c52dec6c2dce2c` (`git merge --no-ff`, strategy `ort`; merge message `docs(phase-4bm-x): merge descriptive diagnostics interpretation`).

## 7. Merge-closeout commit SHA (placeholder / planned finalization note)

The merge-closeout commit is `docs(phase-4bm-x): add merge closeout` (this file's first commit). A commit SHA cannot self-reference; the merge-closeout commit SHA is recorded by the follow-up SHA-finalization commit and captured in the final operator report and git log.

## 8. Final SHA-finalization plan

Following the repo convention used for Phase 4bm-W / 4bm-V / 4bm-U / 4bm-T, the merge-closeout commit SHA is filled in by a follow-up SHA-finalization edit (§ SHAs table below), and the SHA-finalization commit's own SHA is captured in the final operator report and git log rather than by impossible self-reference. After the SHA-finalization commit is pushed, final `main` SHA == final `origin/main` SHA == the SHA-finalization commit.

### SHAs table (final SHA-finalization)

| Item | SHA |
| --- | --- |
| Base SHA (`main` before merge) | `e4067c08c88e6dd8354a15bc90e90aa55ddada39` |
| Docs commit | `199c8c8a840a9614d61f03c93d18df5364559bb4` |
| Branch tip SHA before merge | `199c8c8a840a9614d61f03c93d18df5364559bb4` |
| Merge commit SHA | `70e13ebd9133684e6e8c1d24c2c52dec6c2dce2c` |
| Merge-closeout commit SHA | _(filled by SHA-finalization)_ — commit `docs(phase-4bm-x): add merge closeout`; recorded below and in the final operator report and git log |
| SHA-finalization commit SHA | the commit `docs(phase-4bm-x): finalize merge closeout shas`; captured in the final operator report and git log; after this commit final `main` == final `origin/main` == this SHA |

## 9. Validation commands and results

| Check | Result |
| --- | --- |
| `git diff --check main..<branch>` | clean (exit 0) |
| `git diff --stat main..<branch>` | 3 files changed, 429 insertions(+) |
| `git diff --name-status main..<branch>` | `M current-project-state.md`; `A 2026-05-25_phase-4bm-x_closeout.md`; `A 2026-05-25_phase-4bm-x_descriptive-diagnostics-interpretation-memo.md` |
| `git status --short` (pre/post merge) | clean; no `data/microstructure/` and no `data/research/` entry |
| `git check-ignore -v data/research/microstructure/diagnostics/phase-4bm-w/…` | `.gitignore:88: data/research/` (diagnostic outputs gitignored) |

No source, test, committed-script, or configuration file changed; therefore `ruff` / `mypy` / `pytest` were deliberately not re-run (no project-specific markdown-lint gate exists in this repository; none invented). The latest authoritative whole-repo validation remains the predecessor merges; no new whole-repo validation success is claimed. The Phase 4bm-X branch performed no diagnostics, no ML, no strategy, no backtests, and no acquisition.

### 9.1 Local diagnostic output verification (read-only; gitignored; not committed)

All four primary Phase 4bm-W diagnostic outputs re-hashed at merge time and match the recorded values exactly:

| Output | SHA256 | Status |
| --- | --- | --- |
| `descriptive_diagnostics_summary.json` | `f4b825af2e81734007be06acac5083e2d4048b54b5650bc407d87a6fc246198a` | MATCH (gitignored) |
| `descriptive_diagnostics_summary.json.sha256` | `ff52873c983b55cc74a0639d17ea8b3d128cdbee9c77763cd11d2e71b3820473` | MATCH (gitignored) |
| `diagnostics_manifest.json` | `ac10061d2f0257002e094d578bcc6149b1a74ca28c604fd0d0a97e5c51c26e45` | MATCH (gitignored) |
| `diagnostics_manifest.json.sha256` | `644506e392db46da6d27fa46519cac327136b1a05e350e2d9b231c62fce517eb` | MATCH (gitignored) |

The per-day and per-split CSV table SHA256s are recorded inside `diagnostics_manifest.json`. No `data/research/` output is staged or committed.

## 10. File inventory / changed files

Docs (3 files):

- `docs/00-meta/implementation-reports/2026-05-25_phase-4bm-x_descriptive-diagnostics-interpretation-memo.md` (added)
- `docs/00-meta/implementation-reports/2026-05-25_phase-4bm-x_closeout.md` (added)
- `docs/00-meta/current-project-state.md` (modified — narrow Phase 4bm-X "Current phase:" block prepended; prior Phase 4bm-W block preserved as labelled historical context)

```text
 docs/00-meta/current-project-state.md              |   2 +
 .../2026-05-25_phase-4bm-x_closeout.md             | 122 +++++++++
 ..._descriptive-diagnostics-interpretation-memo.md | 305 +++++++++++++++++++++
 3 files changed, 429 insertions(+)
```

No source / test / committed-script / configuration file was changed. No `data/microstructure/` file was modified or committed. No `data/research/` output was committed (the research-output namespace is gitignored). No manifest, sidecar, gate report, or successor-state artefact was changed. No prior governance memo was modified beyond the narrow `current-project-state.md` block addition. This merge-closeout (`2026-05-25_phase-4bm-x_merge-closeout.md`) is committed separately on `main`.

## 11. Interpretation decision

`RECOMMEND_AUTHORIZE_ML_READINESS_SCOPING_MEMO`.

This recommends only that a future, separately authorized, docs-only ML-readiness scoping memo *may* be proposed. It authorizes no ML, no model training, no feature selection, no model selection, no threshold tuning, no strategy research, no backtests, no acquisition, and no research execution.

## 12. Confirmation all ML-readiness scoping criteria A–M PASS

| # | Criterion | Result |
| --- | --- | --- |
| A | Descriptive diagnostics completed successfully | PASS |
| B | Diagnostic verdict has 0 blocking structural failures | PASS |
| C | Non-blocking caveats understood; no remediation required before a scoping memo | PASS |
| D | Split policy applied correctly; can govern future ML scoping | PASS |
| E | Test holdout not used for tuning or design | PASS |
| F | Feature/label alignment strict 1:1 across all 90 days | PASS |
| G | Label availability and censoring behavior understood | PASS |
| H | Distribution summaries reveal no structural impossibility for scoping | PASS |
| I | Missingness / value-domain checks passed | PASS |
| J | Local diagnostic outputs exist, gitignored, reproducible via recorded hashes | PASS |
| K | No manifest or successor-state mutation occurred | PASS |
| L | No ML / strategy / backtest work authorized or run | PASS |
| M | Retained verdicts and project locks unchanged | PASS |

**All ML-readiness scoping criteria A–M PASS.**

## 13. Phase 4bm-W diagnostic verdict

`DESCRIPTIVE_DIAGNOSTICS_PASS_WITH_CAVEATS` (descriptive-only; not ML-readiness, strategy-readiness, or backtest-readiness). Phase 4bm-X interprets this verdict; it does not change, re-derive, or rerun it.

## 14. Blocking failure interpretation

**0 blocking structural failures.** Every structural and alignment violation counter in the Phase 4bm-W summary aggregates to zero (`censor_rule_mismatch`, `censored_row_not_null`, `direction_domain_violation`, `direction_sign_mismatch_vs_return`, `any_censored_flag_mismatch`, `row_index_violation`, `src_ne_feature_ts`, `out_of_partition_day`, `split_assignment_mismatch`, `invalid_price_row_count`, plus `symbol` / `dataset_version` / `label_config_hash` constancy and all six feature/label alignment fields). The absence of blocking failures is the precondition that distinguishes a `PASS_WITH_CAVEATS` verdict from a defer or do-not-recommend posture.

## 15. Caveat interpretation

Four non-blocking caveats; each understood, bounded, and expected; none requires remediation before an ML-readiness scoping memo; each carried forward as a stated constraint inside any future scoping memo.

1. **857 envelope-terminal censored rows, all in the test split** (`{1s:14, 5s:39, 15s:170, 60s:634}`; train/validation 0; envelope terminal `1740787199996` ms = 2025-02-28 23:59:59.996Z). Known, expected, additive structural asymmetry — labels at the largest horizons are not computable past the envelope terminal. Not missingness of unknown origin and not a defect. Carry forward as a horizon-availability-by-split constraint; treat censored rows as label-unavailable; keep test-window censoring out of any tuning/design loop.
2. **538 embargo-excluded earlier-split rows** (train 248 at `T_TV = 2025-01-15T00:00:00Z`; validation 290 at `T_VT = 2025-02-14T00:00:00Z`; test 0). The intended leakage-control behavior of the Phase 4bm-U 60s boundary embargo; per-row masks only, no parquet rewrite; ≈ 3.5e-6 of the corpus — negligible. Carry forward as an embargo-rule restatement.
3. **Approximate-quantile method** (fixed-width histogram, range ±0.02, bin width 1e-05). Pertains only to descriptive distribution reporting; exact additive moments (mean / std / min / max) are not approximate. A scoping memo does not depend on exact quantiles; if ever needed they could be recomputed exactly by a future separately authorized phase. A precision caveat on a report field, not a structural defect.
4. **Historical `diagnostics_authorized=false` manifest flag.** The v002 manifests carry a historical flag predating Phase 4bm-W; authorization for the diagnostics derived from the operator prompt, not from manifest mutation, and the manifests were left byte-identical. Consistent with the project's deliberate separation of governance state from on-disk artefacts; the flag's value is expected and correct as-is and must not be mutated. Any future change to a manifest authorization flag would itself require its own separately authorized phase and must honor the Phase 4aw `flip_research_eligible(...)` always-raises invariant.

## 16. Validation discrepancy interpretation

The Phase 4bm-W branch implementation report and closeout stated **"45 passed"** for the three new pytest suites; merge-time verification (recorded in the Phase 4bm-W merge-closeout §8) found the accurate re-verified count was **"33 passed"**. This is a **documentation overcount only** — not a test failure. Every listed suite passed (33/33); no test was skipped, errored, or failed; and the diagnostic verdict is unchanged. The discrepancy concerns a reported integer, not test outcomes, code behavior, or any diagnostic result, and bears on no ML-readiness scoping criterion (the structural/alignment evidence underpinning the verdict is independent of the pytest count). Phase 4bm-X recorded and interpreted this discrepancy in §15 of the interpretation memo; it does not warrant defer or do-not-recommend.

## 17. Confirmation Phase 4bm-X is recommendation-only and authorizes nothing

Phase 4bm-X records a single governance recommendation (`RECOMMEND_AUTHORIZE_ML_READINESS_SCOPING_MEMO`). It is a recommendation only. It does not authorize any ML-readiness scoping memo, any ML, any model training, any feature/model/threshold selection, any strategy, any backtest, any acquisition, or any research execution. **Any ML-readiness scoping requires a separately authorized memo phase.**

## 18. Confirmation no diagnostics were rerun

No diagnostic was run or rerun; Phase 4bm-W was not re-executed; the Phase 4bm-W diagnostic outputs were read-only and re-hashed byte-identical (§9.1). **Phase 4bm-X does not run diagnostics.**

## 19. Confirmation no ML was run

No ML model was trained, scored, or evaluated. **Phase 4bm-X does not run ML.**

## 20. Confirmation no strategy was defined or run

No strategy was specified, designed, implemented, or signalled. **Phase 4bm-X does not define or run strategy.**

## 21. Confirmation no backtests were run

No PnL simulation, backtest, or walk-forward optimization was run. **Phase 4bm-X does not run backtests.**

## 22. Confirmation no acquisition was authorized

No data was acquired; no public / authenticated / private endpoint was called; no WebSocket / user-stream was opened; no credential / `.env` / `.mcp.json` was read or created; MCP / Graphify were not enabled. **Phase 4bm-X does not authorize acquisition.**

## 23. Confirmation no research execution was authorized

No row-level research execution beyond the already-merged Phase 4bm-W descriptive diagnostics occurred or was authorized. **Phase 4bm-X does not authorize research execution.**

## 24. Confirmation no ML artefact was created

No ML artefact (model, weights, feature ranking, prediction, score, split mask for later research use) was created. **Phase 4bm-X does not create ML artefacts.**

## 25. Confirmation no diagnostic artefact was created

No new diagnostic artefact was created; the only diagnostic outputs in the repo remain the gitignored Phase 4bm-W outputs (unchanged). **Phase 4bm-X does not create diagnostic artefacts.**

## 26. Confirmation no feature/model/threshold selection occurred

No feature ranking, feature selection, model selection, hyperparameter selection, or threshold tuning occurred. **Phase 4bm-X does not perform feature selection.** **Phase 4bm-X does not perform model selection.** **Phase 4bm-X does not perform threshold tuning.**

## 27. Confirmation test holdout not used for tuning/design

The 15-date test / final holdout was not used for tuning or design in this phase; Phase 4bm-X only interprets the Phase 4bm-W result, in which the holdout was summarised descriptively only. **Phase 4bm-X does not use the test holdout for tuning or design.**

## 28. Confirmation no manifest was mutated

The v002 label manifest (`5e17074d…`) and v002 feature manifest (`512a0a54…`) are byte-identical pre/post (re-hash MATCH); manifest `chronological_split_policy` remains `"not_yet_defined"`. **Phase 4bm-X does not mutate any manifest.**

## 29. Confirmation no successor-state artefact was mutated

The Phase 4bm-S research-use successor-state JSON (`081730006c…`) and the Phase 4bm-U split-policy successor-state JSON (`6834ab11…`) are byte-identical pre/post (re-hash MATCH); the Phase 4bm-Q gate report (`8a360608…`) is byte-identical pre/post; the gate was not re-run. The Phase 4aw `MicrostructureManifest.flip_research_eligible(...)` always-raises invariant is preserved (never invoked). **Phase 4bm-X does not mutate any successor-state artefact.**

## 30. Confirmation no data/microstructure artefact was committed

`git status --short` shows no `data/microstructure/` entry; the merge brought only the three docs files. No `data/microstructure/` artefact is staged or committed. **Phase 4bm-X does not commit data/microstructure.**

## 31. Confirmation no data/research artefact was committed

`git status --short` shows no `data/research/` entry; the Phase 4bm-W diagnostic outputs remain gitignored under `.gitignore:88: data/research/` and uncommitted. **Phase 4bm-X does not commit data/research.**

## 32. Confirmation Phase 4bm-Y and all successors remain unauthorized

No successor phase is authorized. **Phase 4bm-Y is not authorized by Phase 4bm-X.** Candidate successors that are **not** authorized: Phase 4bm-Y (any future phase); any ML-readiness scoping memo; multi-day v002 ML training / model selection / feature ranking / feature selection / hyperparameter selection / threshold tuning / meta-labeling; multi-day v002 strategy specification / implementation / signal construction; multi-day v002 backtest specification / execution / walk-forward optimization; multi-day v002 research execution; split-mask materialization for later research use; additional acquisition; Phase 4bn-* / 4bo-* / 4bp-* / 4bq-*; Phase 5; Phase 4 canonical; paper / shadow; live-readiness; deployment; exchange-write; production keys; authenticated APIs; private endpoints; user streams / WebSockets; MCP / Graphify / `.mcp.json` / credentials. Each future phase requires its own separately authorized operator prompt under the Phase 4bk-A workflow standard, the Phase 4bl-F four-tier risk model, the Phase 4bm-A-P1 thin-prompt context-management standard, the Phase 4bm-D-P1 lightweight Claude Code workspace standard, the operator-report standard, and the merge-closeout standard.

## 33. Retained verdicts preserved

All preserved verbatim:

- **H0** — FRAMEWORK ANCHOR
- **R3** — BASELINE-OF-RECORD
- **R1a** — RETAINED — NON-LEADING
- **R1b-narrow** — RETAINED — NON-LEADING
- **R2** — FAILED — §11.6
- **F1** — HARD REJECT
- **D1-A** — MECHANISM PASS / FRAMEWORK FAIL
- **5m thread** — OPERATIONALLY CLOSED
- **V2** — HARD REJECT — terminal for V2 first-spec
- **G1** — HARD REJECT — terminal for G1 first-spec
- **C1** — HARD REJECT — terminal for C1 first-spec

All prior phase results (Phase 4am .. Phase 4bm-W) preserved verbatim.

## 34. Project locks preserved

All preserved verbatim:

- §11.6 = 8 bps per side
- round-trip = 16 bps
- §1.7.3 = 0.25% risk / 2× leverage / one-position / mark-price stops
- Phase 3p §4.7; Phase 3r §8; Phase 3v §8; Phase 3w §6 / §7 / §8
- Phase 4j §11; Phase 4k; Phase 4p; Phase 4q; Phase 4v; Phase 4w
- Phase 4ak M0 twelve-clause gate + post-null cooldown rule + cooled-down families list + memo template
- Phase 4al refined no-rescue rule + §13 boundary + §14 hierarchy
- Phase 4aw `MicrostructureManifest.flip_research_eligible(...)` always-raises invariant (never invoked by Phase 4bm-X)
- Phase 4bb-F canonical sidecar / path policy
- Phase 4bl-F four-tier risk model + R-SIDECAR-CRLF standing rule + nine reusable non-authorization blocks
- Phase 4bm-A-P1 thin-prompt context-management standard
- Phase 4bm-D-P1 lightweight Claude Code workspace standard

## 35. Known caveats

- The Phase 4bm-W branch-doc "45 passed" vs. merge-verified "33 passed" pytest overcount is documentation-only; all listed suites passed and the diagnostic verdict is unchanged (§16).
- The four Phase 4bm-W descriptive-diagnostics caveats (§15) are non-blocking and carried forward as stated constraints for any future ML-readiness scoping memo.
- Whole-repo `pytest` remains affected by the documented baseline httpx/duckdb collection errors and 2 pre-existing backtest subprocess failures — unchanged by this docs-only phase; no whole-repo validation was re-run.

## 36. Recommended state

**Remain paused.** Phase 4bm-X is now project-complete after this merge-closeout and its SHA-finalization. The interpretation decision `RECOMMEND_AUTHORIZE_ML_READINESS_SCOPING_MEMO` is a recommendation only and authorizes nothing.

**Conditional next, NOT authorized:** a future docs-only ML-readiness scoping memo (provisionally a "Phase 4bm-Y"-class phase) would, if separately authorized, define what ML-readiness scoping should evaluate at memo level only (task framing, target/horizon admissibility, train/validation/test usage rules, metrics, leakage controls, baseline model families to consider without training them, sample-weighting / class-imbalance / calibration / cost-aware policy questions, and whether a later ML-baseline implementation phase may be proposed) and would remain forbidden from training/selecting/ranking/tuning anything, designing strategy, generating signals, simulating PnL, backtesting, using the test holdout for tuning/design, mutating any manifest or successor state, or acquiring data. It is **not** authorised by this merge.

**Any ML-readiness scoping requires a separately authorized memo phase.** **Phase 4bm-Y is not authorized by Phase 4bm-X.** **Recommended state remains paused.**
